Showing results (761-770 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|April 1, 1994
Elevated serum homocysteine as a predictor for vitamin B12 or folate deficiencyD Curtis, R Sparrow, L Brennan, et al.
European Journal of Haematology|September 1, 1994
Idiopathic erythrocytosis--additional new study techniques suggest a heterogenous groupM Messinezy, B Sawyer, N B Westwood, et al.
European Journal of Haematology|September 1, 1994
Revisited indications for bone marrow examinations in HIV-infected patientsM Ciaudo, T Doco-Lecompte, C Guettier, et al.
European Journal of Haematology|October 1, 1994
Pattern of iron excretion in relation to haemoglobin level and iron load in 8 haematological patients following the administration of subcutaneous deferrioxamineA Di Palma, S Moratelli, P Tolomelli, et al.
European Journal of Haematology|October 1, 1994
Recombinant alpha 2a interferon and polycythemia vera: clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopyF Papineschi, A Bucalossi, E Capochiani, et al.
European Journal of Haematology|April 16, 2002
Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cellsY Yu, R Rabinowitz, A Polliack, et al.
European Journal of Haematology|April 16, 2002
Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 casesAnn Nordgren, Mats Heyman, Sigrid Sahlén, et al.
European Journal of Haematology|August 1, 1994
Cell function studies in long-term bone marrow culture after cell concentration and cryopreservation for autologous transplantationR Gilabert, R Ayats
European Journal of Haematology|January 1, 1995
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosisA Diez-Ruiz, G P Tilz, R Zangerle, et al.
European Journal of Haematology|January 1, 1995
Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre studyG J Ruiz-Argüelles, M G Apreza-Molina, D D Alemán-Hoey, et al.
Pageof 527